Immediate Impact
77 standout
Citing Papers
EASL Clinical Practice Guidelines on the management of hepatocellular carcinoma
2024 Standout
Adjuvant sintilimab in resected high-risk hepatocellular carcinoma: a randomized, controlled, phase 2 trial
2024 Standout
Works of K.T. Sato being referenced
A Comparative Analysis of Transarterial Downstaging for Hepatocellular Carcinoma: Chemoembolization Versus Radioembolization
2009
Fibrosis, Portal Hypertension, and Hepatic Volume Changes Induced by Intra-arterial Radiotherapy with 90Yttrium Microspheres
2008
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| K.T. Sato | 564 | 212 | 149 | 264 | 15 | 605 | |
| Ali Habib | 587 | 334 | 139 | 288 | 13 | 710 | |
| Rohi Atassi | 497 | 210 | 141 | 195 | 9 | 583 | |
| Zhi-Ping Yan | 390 | 187 | 103 | 122 | 24 | 525 | |
| Yann Lachenal | 418 | 140 | 132 | 171 | 9 | 541 | |
| Ye‐Qin Yu | 490 | 179 | 109 | 205 | 18 | 553 | |
| Leigh Casadaban | 371 | 288 | 102 | 216 | 25 | 637 | |
| Toru Arano | 527 | 198 | 102 | 405 | 17 | 729 | |
| Fabrizio Magnolfi | 449 | 211 | 146 | 289 | 13 | 707 | |
| É. Boucher | 390 | 137 | 132 | 234 | 13 | 548 | |
| Saya Igarashi | 254 | 318 | 117 | 224 | 21 | 630 |
All Works
Login with ORCID to disown or claim papers
Loading papers...